My company has gone through 3 growth cycles in 18 months. Here’s how I navigated them
Extend partners with Guardsman marking the company's expansion into offering furniture protection plans
Activ Surgical Named to Healthcare Tech Outlook’s Top 10 Surgical Solutions of 2020
Q&A with Tailored Brands: How they Adapted Omnichannel Retail to the COVID-19 Era
K2 Cyber Security Partners with GuardSight to Secure Critical Web Applications and Container Workloads
Earth Challenge 2020 Releases Native Insect and Food Security Citizen Science Applications Built on Kinetica in Support of National Insect Week
Truvian Sciences Expands Focus to Address Surge in Demand for Antibody Tests; Introduces Easy Check COVID-19 IgM/IgG™ Test
Skyhawk Therapeutics Announces Expansion of its Collaboration Agreement with Merck to Discover and Develop Novel Small Molecules that Modulate RNA Splicing
A test that aims to rule out autism using a strand of hair is now available to the public
Ipsen and Skyhawk Therapeutics announce RNA targeting research collaboration in rare neurological diseases
Datalogz Secures $5 Million Funding Led by GreatPoint Ventures, Unveiling Their Groundbreaking Solution to End Business Intelligence (BI) Sprawl Across Fortune 500 Enterprises
Recogni claims world’s fastest computing system for autonomous driving
Onymos raises $12M, led by GreatPoint Ventures, to provide plug-in features for apps
Hacking Postgres: DJ Patil and Ray Lane Interview, GreatPoint Ventures -- YouTube
Pete Soderling's Zero Prime Podcast: Episode 13 with DJ Patil. Pete and DJ speak about all things data!
Examining the "Integration Layer" - Breaking down GreatPoint's investment in Onymos
Episode 2: Interview with our Co-founder and Chief Business Officer, Ashwini Choudhary
Ep. 9 R K Anand, CEO & Co-Founder, Recogni
Join the BMW iVentures team as they speak with CEO and Co-Founder of Recogni, RK Anand, on the company’s advancement of visual-perception technology in autonomous vehicles.
Q&A with Tailored Brands: How they Adapted Omnichannel Retail to the COVID-19 Era